Public markets are a key fundraising source for life sciences companies developing new drugs and disease therapies.
In an Axios article, life sciences transactions partner Ray Grant noted that life sciences companies are starting to go public a little earlier in their lifecycle and using three different methods including initial public offerings (IPOs), de-SPACs, and reverse mergers. Reverse mergers and de-SPACs include raising capital through concurrent PIPEs (Private Investment in Public Equity).
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.